Collaborations
-
Hugel Inc.
Hypertrophic scar program (OLX101A) License and Collaboration Agreement
-
Théa Open Innovation by Laboratoires Théa S.A.S
Ophthalmic programs (OLX301A · OLX301D) License and Collaboration Agreement
-
Hansoh Pharmaceuticals Group Co, Ltd
Cardiovascular/metabolic programs (GalNAc-asiRNA) License and Collaboration Agreement
-
University of Virginia School of Medicine
GA and Wet AMD program (OLX301A) Research Collaboration
-
AM Chemicals
GalNAc platform technology introduced
-
Charles River Laboratories
GA & Wet AMD program (OLX301A) Toxicology Studies
-
ASTAR – IMCB(Singapore)
A*STAR(Singapore)-KHIDI(Korea) Joint Grant Call
Idiopathic pulmonary fibrosis program (OLX201A) -
Korea Institute of Toxicology, Department of Inhalation Research
Idiopathic pulmonary fibrosis program (OLX201A) Development Collaboration